Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 1997

View Archived Issues

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Gliatech awarded SBIR grant to clone H3 receptor

Sequana receives Phase I SBIR grant for RAMMP technology

FK-037, a beta-lactam with potent activity against MRSA

Vistide launched in Germany

Potential agent for hepatitis enters clinical trials at Bristol-Myers Squibb

Fujisawa prepares novel antileukotriene agents

New isooxacephems from Roche

Cyclic peptide antifungal/antiparasitic agents disclosed by Lilly

NIH contemplates licensing liposomal delivery technology to Biovector Therapeutics

Merck & Co. focuses on farnesyltransferase inhibitors

Natural antifungal agent discovered at Merck & Co.

Spotlight on drugs for treatment of picornavirus

Leukotriene antagonists useful for asthma claimed by Bayer

Abbott describes synthesis and evaluation of novel erythromycin derivatives

P&G presents new quinolonyl-lactams

Millennium and Lilly extend cardiovascular research collaboration

Carboxyfullerenes as neuroprotective agents

Empi's new incontinence device approved by FDA; worldwide launch slated for January

Abbott presents new ketolides based on TE-802

Synthesis and biological evaluation reported for quinolonyl-carbacephems

NTZ: a potential new anti-H. pylori agent

Therapeutic Antibodies' CytoTAb enters clinical trials

ViroPharma evaluates pleconaril in phase II

Epimmune issued U.S. patent for cancer therapeutic

Knoll receives FDA approval for Vicoprofen

Sertraline alleviates symptoms in severe premenstrual syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...